Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 176789, 8 pages
http://dx.doi.org/10.5402/2012/176789
Clinical Study

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial

1Department of Oncology, Oslo University Hospital, 0424 Oslo, Norway
2Faculty of Medicine, University of Oslo, Oslo, Norway
3Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway
4AstraZeneca, R&D, Mereside Alderley Park, Macclesfield, UK

Received 24 January 2012; Accepted 29 February 2012

Academic Editors: A. M. Garcia-Lora and C. Nicco

Copyright © 2012 Olav Engebraaten et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary Table 1 contains information on genomic position, suggested function, associated gene and assay ID for the studied SNPs.

  1. Supplementary Material